Tempest Therapeutics Inc (TPST) - Total Liabilities

Latest as of December 2025: $10.26 Million USD

Based on the latest financial reports, Tempest Therapeutics Inc (TPST) has total liabilities worth $10.26 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore TPST cash generation efficiency to assess how effectively this company generates cash.

Tempest Therapeutics Inc - Total Liabilities Trend (2011–2025)

This chart illustrates how Tempest Therapeutics Inc's total liabilities have evolved over time, based on quarterly financial data. Check TPST cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Tempest Therapeutics Inc Competitors by Total Liabilities

The table below lists competitors of Tempest Therapeutics Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Scandinavian Enviro Systems AB ST:SES	Sweden	Skr56.45 Million
Sun Peak Metals Corp V:PEAK	Canada	CA$47.14K
SCI Electric Public Company Limited BK:SCI	Thailand	฿911.77 Million
Despec Bilgisayar Pazarlama ve Ticaret AS IS:DESPC	Turkey	TL4.39 Billion
Rossell India Limited NSE:ROSSELLIND	India	Rs1.12 Billion
Seoul Electronics & Telecom Co. Ltd KQ:027040	Korea	₩42.33 Billion
Lyckegard Group AB ST:LYGRD	Sweden	Skr67.36 Million
Gromutual Bhd KLSE:9962	Malaysia	RM116.08 Million

Liability Composition Analysis (2011–2025)

This chart breaks down Tempest Therapeutics Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Tempest Therapeutics Inc worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.50	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.54	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.61	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Tempest Therapeutics Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Tempest Therapeutics Inc (2011–2025)

The table below shows the annual total liabilities of Tempest Therapeutics Inc from 2011 to 2025.

Year	Total Liabilities	Change
2025-12-31	$10.26 Million	-54.11%
2024-12-31	$22.36 Million	-9.96%
2023-12-31	$24.84 Million	-11.23%
2022-12-31	$27.98 Million	-24.63%
2021-12-31	$37.12 Million	-59.50%
2020-12-31	$91.66 Million	+507.03%
2019-12-31	$15.10 Million	+37.87%
2018-12-31	$10.95 Million	+126.80%
2017-12-31	$4.83 Million	-66.29%
2016-12-31	$14.32 Million	+21.78%
2015-12-31	$11.76 Million	+14.79%
2014-12-31	$10.25 Million	+75.34%
2013-12-31	$5.84 Million	+179.22%
2012-12-31	$2.09 Million	+174.67%
2011-12-31	$762.00K	--

About Tempest Therapeutics Inc

NASDAQ:TPST USA Biotechnology

Market Cap

$29.26 Million

Market Cap Rank

#24634 Global

#5042 in USA

Share Price

$2.04

Change (1 day)

+2.51%

52-Week Range

$1.52 - $11.83

All Time High

$3314.25